- Home
- IMCC vs EVOK Comparison
IMCC vs EVOK Comparison
Compare IMCC & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMCC
- EVOK
- Stock Information
- Founded
- IMCC 1980
- EVOK 2007
- Country
- IMCC Israel
- EVOK United States
- Employees
- IMCC N/A
- EVOK N/A
- Industry
- IMCC Medicinal Chemicals and Botanical Products
- EVOK Biotechnology: Pharmaceutical Preparations
- Sector
- IMCC Health Care
- EVOK Health Care
- Exchange
- IMCC Nasdaq
- EVOK Nasdaq
- Market Cap
- IMCC 12.0M
- EVOK 4.2M
- IPO Year
- IMCC N/A
- EVOK 2013
- Fundamental
- Price
- IMCC $2.95
- EVOK $6.09
- Analyst Decision
- IMCC
- EVOK
- Analyst Count
- IMCC 0
- EVOK 0
- Target Price
- IMCC N/A
- EVOK N/A
- AVG Volume (30 Days)
- IMCC 148.9K
- EVOK 7.2M
- Earning Date
- IMCC 08-13-2025
- EVOK 08-12-2025
- Dividend Yield
- IMCC N/A
- EVOK N/A
- EPS Growth
- IMCC N/A
- EVOK N/A
- EPS
- IMCC N/A
- EVOK N/A
- Revenue
- IMCC $37,894,737.00
- EVOK $11,594,083.00
- Revenue This Year
- IMCC $47.12
- EVOK $57.82
- Revenue Next Year
- IMCC $12.83
- EVOK $59.12
- P/E Ratio
- IMCC N/A
- EVOK N/A
- Revenue Growth
- IMCC 12.68
- EVOK 89.89
- 52 Week Low
- IMCC $1.29
- EVOK $1.94
- 52 Week High
- IMCC $7.12
- EVOK $12.32
- Technical
- Relative Strength Index (RSI)
- IMCC 51.60
- EVOK 74.84
- Support Level
- IMCC $2.37
- EVOK $2.52
- Resistance Level
- IMCC $3.75
- EVOK $9.88
- Average True Range (ATR)
- IMCC 0.38
- EVOK 0.49
- MACD
- IMCC 0.03
- EVOK 0.39
- Stochastic Oscillator
- IMCC 41.99
- EVOK 49.19
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.